Skip to content

Vaalco Energy EGY Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By segment

See full
Egypt100%0.0%
Canada47%-9.6%
Côte d'Ivoire0%-100%

Other financials

Income statement

See full
Revenue$62.6M-43.3%
Operating income-$16.1M-162%
Net income-$93.8M-1,313%
EPS (diluted)-$0.90-1,386%

Balance sheet

See full
Cash & equivalents$48.0M+17.4%
Total debt$240.3M+149%
Total equity$344.9M-31.6%
Total assets$920.7M-0.7%

Cash flow

See full
Operating cash flow-$39.2M-220%
CapEx$9.8M+53.5%
Free cash flow-$49.0M-286%

Valuation

See full
Market cap$536.13M+33.2%
Enterprise value$728.42M+59.1%
P/S1.7×+0.9×

Profitability

See full
Operating margin-20.2%-46.6pp
Net margin-45.9%-57.8pp
FCF margin41.5%+15.3pp

Returns & leverage

See full
Return on equity-33.7%-45.6pp
Debt / equity0.7×+0.5×
Current ratio0.5×-0.6×